Hanger (HNGR) Stock Price, News & Analysis

Company Overview

Hanger, Inc. provides orthotic and prosthetic (O&P) services in the United States. It operates in two segments, Patient Care and Products & Services. The Patient Care segment owns and operates Hanger clinic, which specializes in the design, fabrication, and delivery of custom O&P devices through patient care clinics and satellite locations; and offers payor network contracting services to other O&P providers. The Products & Services segment engages in the distribution of various O&P parts, componentry, and devices to independent O&P providers; development of specialized rehabilitation technologies; and provision of evidence-based clinical programs for post-acute rehabilitation to patients at approximately 4,000 skilled nursing and post-acute providers. This segment also manufactures and sells therapeutic footwear for diabetic patients in the podiatric market. As of December 31, 2021, the company operated approximately 760 patient care clinics and 115 satellite locations in 47 states and the District of Columbia. It also distributes O&P devices and components, manages O&P networks, and provides therapeutic solutions to patients and businesses in acute, post-acute, and clinic settings. The company was formerly known as Hanger Orthopedic Group, Inc. and changed its name to Hanger, Inc. in June 2012. Hanger, Inc. was founded in 1861 and is headquartered in Austin, Texas.

Key Stats

• Today's Range: $18.72 to $18.72
• 50-Day Range: $18.63 to $18.72
• 52-Week Range: $13.42 to $22.67
• Volume: N/A
• Average Volume: 356,429 shs
• Market Capitalization: $732.38 million
• P/E Ratio: 19.71
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Hanger Stock Analysis - MarketRank™

Hanger scored higher than 23% of companies evaluated by MarketBeat, and ranked 816th out of 920 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Hanger.

Earnings and Valuation

• Score: 1.9 / 5
• Proj. Earnings Growth: 5.26%

Earnings Growth

Earnings for Hanger are expected to grow by 5.26% in the coming year, from $1.14 to $1.20 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Hanger is 19.71, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 24.74.

Price to Earnings Ratio vs. Sector

The P/E ratio of Hanger is 19.71, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 26.99.

Price to Book Value per Share Ratio

Hanger has a P/B Ratio of 6.57. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: N/A
• Short Interest Level: N/A

Short Interest

There is no current short interest data available for HNGR.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Hanger does not currently pay a dividend.

Dividend Growth

Hanger does not have a long track record of dividend growth.

Sustainability and ESG

• Score: 4.4 / 5
• Environmental Score: -0.86

Short Interest

There is no current short interest data available for HNGR.

News and Social Media

• Score: 0.0 / 5
• News Sentiment: -0.06

News Coverage This Week

MarketBeat has tracked 2 news articles for Hanger this week, compared to 0 articles on an average week.

Company Ownership

• Score: 1.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Hanger insiders have not sold or bought any company stock.

Percentage Held by Insiders

Only 4.36% of the stock of Hanger is held by insiders.

Percentage Held by Institutions

79.17% of the stock of Hanger is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

HNGR Stock Analysis - Frequently Asked Questions

How were Hanger's earnings last quarter?

Hanger, Inc. (NYSE:HNGR) issued its quarterly earnings data on Monday, November, 8th. The company reported $0.39 EPS for the quarter, topping analysts' consensus estimates of $0.27 by $0.12. The firm earned $289.83 million during the quarter, compared to analyst estimates of $282.22 million. Hanger had a trailing twelve-month return on equity of 35.72% and a net margin of 3.17%.

What other stocks do shareholders of Hanger own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Hanger investors own include Gilead Sciences (GILD), Health Insurance Innovations (HIIQ), M&T Bank (MTB), AbbVie (ABBV), Advanced Micro Devices (AMD), Bristol-Myers Squibb (BMY) and Incyte (INCY).

Company Calendar

• Last Earnings: 11/08/2021
• Today: 5/27/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Medical
• Industry: Specialty Outpatient Clinics
• Sub-Industry: N/A
• Current Symbol: NYSE:HNGR
• CIK: 722723
• Web: www.hanger.com
• Phone: (512) 777-3800
• Fax: 301-986-0702
• Employees: 5,200
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): $0.95
• Trailing P/E Ratio: 19.71
• Forward P/E Ratio: 16.42
• P/E Growth: N/A
• Net Income: $41.98 million
• Net Margins: 3.17%
• Pretax Margin: 3.31%
• Return on Equity: 35.72%
• Return on Assets: 4.00%

Debt

• Debt-to-Equity Ratio: 3.71
• Current Ratio: 1.23
• Quick Ratio: 0.85

Sales & Book Value

• Annual Sales: $1.12 billion
• Price / Sales: 0.65
• Cash Flow: $1.88 per share
• Price / Cash Flow: 9.98
• Book Value: $2.85 per share
• Price / Book: 6.57

Miscellaneous

• Outstanding Shares: 39,123,000
• Free Float: 37,417,000
• Market Cap: $732.38 million
• Optionable: Optionable
• Beta: 1.28